| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/2004 | US6723699 Administering as cholinergic agent to treat nervous system disorders |
| 04/20/2004 | US6723698 Methods and compositions for the treatment of motor neuron injury and neuropathy |
| 04/20/2004 | US6723697 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723694 Short peptides which selectively modulate intracellular signalling |
| 04/20/2004 | US6723561 Polypeptides |
| 04/20/2004 | US6723560 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/20/2004 | US6723558 Comprise mixtures of 10,000 different recombinant viruses that each express a different hiv env variant containing both constant and variable regions; used as vaccines; envelop proteins (env) |
| 04/20/2004 | US6723556 Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor |
| 04/20/2004 | US6723548 Enzymatic polypeptide for use inthe treatment of cell maintenance, immunological and apoptitic defects |
| 04/20/2004 | US6723538 Therapy for infections, immunology diseases |
| 04/20/2004 | US6723534 Polypeptide for use in the treatment of fertility defects in humans |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723506 Nucleotide sequences coding polypeptide for use treatment of tumors |
| 04/20/2004 | US6723354 Methods and means for preventing or treating inflammation or pruritis |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | US6723339 Hard gelatine capsule |
| 04/20/2004 | US6723335 Methods and compositions for treating intervertebral disc degeneration |
| 04/20/2004 | US6723322 Angiogenic Onchocerca volvulus proteins and uses thereof |
| 04/20/2004 | US6723320 Using monoclonal antibodies; polymerase chain reactions |
| 04/20/2004 | US6723319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies |
| 04/20/2004 | US6723318 Targeting of biomolecules |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | US6723315 Method for treating amyotrophic lateral sclerosis |
| 04/20/2004 | US6723314 Use of interleukin-11 to treat gastrointestinal disorders |
| 04/20/2004 | CA2310136C Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031731A2 Methods for controlling proliferation of cells |
| 04/15/2004 | WO2004031722A2 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 04/15/2004 | WO2004031412A2 Method for diagnosing pancreatic cancer |
| 04/15/2004 | WO2004031411A2 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031389A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 04/15/2004 | WO2004031374A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 04/15/2004 | WO2004031367A2 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | WO2004031365A2 Sulfatases and methods of use thereof |
| 04/15/2004 | WO2004031359A2 Method for regulating expression genes |
| 04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | WO2004031352A2 Interferon variants with improved properties |
| 04/15/2004 | WO2004031350A2 Modulation of forkhead box o1a expression |
| 04/15/2004 | WO2004031347A2 Methods and compositions for soluble cpg15 |
| 04/15/2004 | WO2004031276A2 Method of inducing maturation of dendritic cells and uses therefor |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031235A1 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031230A2 Novel mhc ii associated peptides |
| 04/15/2004 | WO2004031226A1 Immunogenic library of chimeric peptides mimicking the genetic diversity of the hypervariable region v3 of the protein of the envelope of a virus gp 120 of human immunodeficiency |
| 04/15/2004 | WO2004031224A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | WO2004031221A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031220A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031219A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031218A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031212A1 Antigenic peptides |
| 04/15/2004 | WO2004031206A2 Products for regulating the degradation of collagen and methods for indentifying same |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | WO2004031144A2 Use of caspase inhibitors as therapeutic agent against radiation-induced injury |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030750A1 Antisense modulation of farnesoid x receptor expression |
| 04/15/2004 | WO2004030712A1 Controlled release therapeutic wound dressings |
| 04/15/2004 | WO2004030702A1 Drug for auditory dysfunction |
| 04/15/2004 | WO2004030697A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | WO2004030695A1 Treatment of vascular diseases |
| 04/15/2004 | WO2004030693A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 04/15/2004 | WO2004030692A1 Combined treatment or acromegaly with a growth hormon receptor antagonist and a dopamine agonist |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030690A1 THERAPEUTIC USES OF β-CASEIN A2 AND DIETARY SUPPLEMENT CONTAINING β-CASEIN A2 |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030688A1 Novel method of controlling apoptosis by controlling interaction between proteins and drug using the same |
| 04/15/2004 | WO2004030687A1 Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
| 04/15/2004 | WO2004030686A1 Peptides and recombinant proteins mimicking interferons |
| 04/15/2004 | WO2004030670A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | WO2004030658A1 Enteric composition for the manufacture of soft capsule wall |
| 04/15/2004 | WO2004030650A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 04/15/2004 | WO2004030639A1 Method for protecting and for modulating dermal-epidermal junctions |
| 04/15/2004 | WO2004030636A2 Human papillomavirus polypeptides and immunogenic compositions |
| 04/15/2004 | WO2004030630A2 Focal calcium channel modulation |
| 04/15/2004 | WO2004030628A2 Adult bone marrow derived stem cells |
| 04/15/2004 | WO2004030619A2 Protein s protects the nervous system from injury |
| 04/15/2004 | WO2004030618A2 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/15/2004 | WO2004030617A2 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 04/15/2004 | WO2004030615A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/15/2004 | WO2004030524A2 Treatment of autism and similar disorders |
| 04/15/2004 | WO2004030522A2 Diagnosis and monitoring of diseases |
| 04/15/2004 | WO2004030519A2 Thymic atrophy |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004022630A3 Water-soluble polymer alkanals |
| 04/15/2004 | WO2004019991A3 Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma |
| 04/15/2004 | WO2004015143A3 Endosymbiotic gammaproteobacterium identified in ecteinascidia turbinata |
| 04/15/2004 | WO2004012757A3 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 04/15/2004 | WO2004011632A3 Oligodendrocyte production from multipotent neural stem cells |
| 04/15/2004 | WO2004010987A3 Use of s1p receptor agonists in heart diseases |
| 04/15/2004 | WO2004009774A3 Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| 04/15/2004 | WO2004009636A3 Gnrh modulator |
| 04/15/2004 | WO2004007552A8 Cytokine receptor |
| 04/15/2004 | WO2004004774A3 Compositions comprising panthetine for the treatment of dyslipidemia |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |